ReachMD

Be part of the knowledge.™

Oncology and Hematology

29

LikeLikedUnlike

Episodes 1-15 of 35

Experts Discuss What the TITAN Trial Means for Managing Patients With mCSPC
Medical Industry Feature
Experts Discuss What the TITAN Trial Means for Managing Patients With mCSPC
- Joelle Hamilton, MD
  Peer
- Michael Fabrizio, MD, FACS
  Peer
- Mahdi Taha, DO
  Peer
Improving Patient Care in SCLC: A Proactive Strategy from Dr. Kalmadi
Medical Industry Feature
Improving Patient Care in SCLC: A Proactive Strategy from Dr. Kalmadi
- Sujith Kalmadi, MD
  Peer
Improving Patient Care in SCLC: A Proactive Strategy from Dr. Porter
Medical Industry Feature
Improving Patient Care in SCLC: A Proactive Strategy from Dr. Porter
- Jason Porter, MD
  Peer
Investigating DLL3-Targeted Immunotherapy: The Potential of T Cells to Fight SCLC
Medical Industry Feature
Investigating DLL3-Targeted Immunotherapy: The Potential of T Cells to Fight SCLC
- Jennifer Caudle, DO
  Peer
- Taofeek K. Owonikoko, MD, PhD
  Peer
Addressing Hesitancy on Biosimilars: From Development to Clinical Practice
Medical Industry Feature
Addressing Hesitancy on Biosimilars: From Development to Clinical Practice
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jerome Goldschmidt, MD
  Peer
Navigating mCRC: A Closer Look at Biomarker Testing
Medical Industry Feature
Navigating mCRC: A Closer Look at Biomarker Testing
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Kristen Ciombor, MD
  Peer
Tailored to Fit: Precision Medicine in Metastatic CRC
Medical Industry Feature
Tailored to Fit: Precision Medicine in Metastatic CRC
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Kristen Ciombor, MD
  Peer
- Mark Lewis, MD
  Peer
Managing Anemia in Patients With Myelofibrosis
Medical Industry Feature
Managing Anemia in Patients With Myelofibrosis
- Ruben Mesa, MD, FACP, MPN Expert
  Peer
Spleen Volume Reduction & Long-Term Survival in Myelofibrosis
Medical Industry Feature
Spleen Volume Reduction & Long-Term Survival in Myelofibrosis
- Ruben Mesa, MD, FACP, MPN Expert
  Peer
Durable Hct Control in Patients with Polycythemia Vera
Medical Industry Feature
Durable Hct Control in Patients with Polycythemia Vera
- Andrew Kuykendall, MD, MPN Expert
  Peer
Reviewing a Real Patient’s Experience With Chronic ITP Therapy
Medical Industry Feature
Reviewing a Real Patient’s Experience With Chronic ITP Therapy
- Barry Goode
  Peer
- Layla Van Doren, MD, MBA
  Peer
- Stephanie Johnston, MSN, NP
  Peer
Comparing Targeted Therapies for Wild-Type RAS Metastatic Colorectal Cancer
Medical Industry Feature
Comparing Targeted Therapies for Wild-Type RAS Metastatic Colorectal Cancer
- Jennifer Caudle, DO
  Peer
- Matthew Dugan, DO
  Peer
Inflammation Biosimilars: Examining the Totality of Evidence for Approval
Medical Industry Feature
Inflammation Biosimilars: Examining the Totality of Evidence for Approval
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Gil Melmed, MD, MS
  Peer
Treating Advanced MSI-H/dMMR CRC: Data from a Clinical Trial
Medical Industry Feature
Treating Advanced MSI-H/dMMR CRC: Data from a Clinical Trial
- John L. Marshall, MD
  Peer
Updates in CLL Treatment: 5 Year Follow-up Data from the CLL14 Trial
Medical Industry Feature
Updates in CLL Treatment: 5 Year Follow-up Data from the CLL14 Trial
- John J. Russell, MD
  Peer
- Joanna Rhodes, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended